Khara Rahul 4

4 · Disc Medicine, Inc. · Filed Feb 11, 2026

AI-generated summary of this filing

Updated Feb 12, 2026

Disc Medicine (IRON) Chief Legal Officer Khara Rahul Receives RSU/Option Awards

What Happened

Khara Rahul, Chief Legal Officer of Disc Medicine (IRON), was granted equity awards on 2026-02-10: 17,000 restricted stock units (RSUs) and 25,500 derivative awards (e.g., option/other equity) at $0.00 (no cash paid). The filings list the awards as acquisitions (code A) and no proceeds were involved.

Key Details

Transaction date: 2026-02-10; Form 4 filed 2026-02-11.
Awards: 17,000 RSUs (grant) and 25,500 derivative awards (grant); both recorded at $0.00 acquisition price.
Vesting: RSUs vest annually in four 25% installments beginning Feb 15, 2027 (F1). The derivative award’s underlying shares vest in 48 equal monthly installments beginning Mar 10, 2026 (F3).
Other note: Footnote F2 indicates 233 shares were purchased under the company’s ESPP on Jan 30, 2026 (reported in holdings disclosures).
Shares owned after the transaction are not specified in the provided report.
Filing timeliness: Form 4 was filed the next day (timely).

Context

These were grants/awards (not open-market purchases or sales). RSUs convert into shares only as they vest and are contingent on continued service; the derivative award vests monthly over four years. Such awards are common as compensation and do not, by themselves, indicate a buy/sell decision.

Form 4

Period: 2026-02-10

Chief Legal Officer

Transactions

Award
Common Stock
[F1][F2]
2026-02-10+17,000→ 55,026 total
Award
Stock Option (Right to Buy)
[F3]
2026-02-10+25,500→ 25,500 total
Exercise: $74.75Exp: 2036-02-09→ Common Stock (25,500 underlying)

Footnotes (3)

[F1]Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2027, subject to the Reporting Person's continued service on each such vesting date.
[F2]Includes 233 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on January 30, 2026.
[F3]The shares underlying this option vest in 48 equal monthly installments commencing on March 10, 2026, subject to the Reporting Person's continued service on each such vesting date.

Signature

By: /s/ Rahul Khara|2026-02-11

1 file